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Abstract

Introduction

This study aimed to compare calcium oxalate
(CaOx) crystalli71ltion in undiluted urine from healthy
men and women with the object of clarifying the difference in stone incidence between the two sexes. Twentyfour hour urine specimens were collected from 37 men
and 28 women. Urinary pH, and concentrations of Ca,
oxalate and urate were measured, and indices of crystallization determined by Coulter Counter particle analysis
following induction of CaOx crystallization by addition
of oxalate. The amount of oxalate required to induce
crystallization was significantly (p < 0.01) higher in
females than in males, as was the overall particle volume deposited after 90 minutes incubation (p < 0.006) .
Scanning electron microscopy revealed larger individual
crystals in female urine, and a greater degree of crystal
aggregation in male urine, although the average overall
size of the precipitated crystal particles did not differ
between the two sexes. There were no significant differences between men and women with regard to median
pH, or Ca and oxalate concentrations, but the median
urate concentrations were slightly, but significantly,
higher (p < 0.05) in the women's urines than in the
men's. It was concluded that the greater risk of CaOx
stones in men is related to an increased propensity to nucleate CaOx crystals per se, rather than to a tendency to
form larger crystalline particles.

Although an increase in the incidence of CaOx stone
formation in women in developing countries has been reported to have occurred during the past three decades
[2], for many years it has been generally accepted on the
basis of extended epidemiological studies that the
male:female ratio for the formation of non-infective
urinary CaOx stones is approximately 2-3:1 [1, 21 , 36].
The general predominance of these stones in males may
perhaps be explained by sex-dependent differences in
concentrations of substances that inhibit or promote
lithogenesis in urine, which, in turn, may be regulated
by sex hormones [30, 33]. A previous study in this laboratory [30] showed that female urine inhibits CaOx
crystal aggregation more potently than male urine,
whereas there was no difference in their respective
effects on crystal growth. That study, however, tested
the effects of the urine samples in an inorganic, aqueous
crystallization system: the physiological relevance of
results obtained from such systems have rightly come to
be questioned, since it is widely acknowledged that they
cannot reproduce the complex conditions operating in
urine itself. Therefore, the aim of the current study was
to study parameters of CaOx crystallization in undiluted
urine of healthy men and women in order to determine
whether the disparity in the incidence of stone formation
between the two sexes can be explained by differences
in the inhibitory effects of their urine on CaOx crystallization. The urinary pH and concentrations of calcium,
oxalate and urate were also determined in order to relate
any observed differences in crystallization parameters to
factors known to influence CaOx crystallization.

Key Words: Urolithiasis, gender differences, calcium
oxalate crystallization, crystal growth , crystal aggregation.

Materials and Methods

• Address for correspondence:
Rosemary L. Ryall
Department of Surgery,
Flinders Medical Centre,
Bedford Park, South Australia 5042,
Australia
Telephone number: (61) 8-204-4191
FAX number: (61) 8-374-0832

Materials
All reagents were of analytical purity. All solutions
were prepared with the highest quality water from a "Hi
Pure" water purification system fitted with a 0.2 µm
pore-size filter (Permutit Australia, Brookvale, NSW,
Australia).
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Figure 1. The minimum amount of oxalate required to
induce detectable CaOx crystallization in 20 ml of urine
of healthy women and men (metastable limit) in mmol/1.
Horizontal lines indicate the median values.
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Figure 2. The total particle volume 90 minutes after induction of crystallization in urines of healthy women and
men. Horizontal lines indicate median values.
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distribution of particle volume and size at 90 minutes,
the volumes of particles falling within a certain channel
of the Coulter Counter were combined for all the men
and for all the women, and the median values plotted in
relation to particle size. Increase in particle volume
with time was expressed as the median value of all values obtained at each time interval, for men and for
women. In order to test whether the crystal volume deposited was a function of the concentration of oxalate in
solution at the commencement of the incubation period,
the total oxalate concentration was calculated by adding
the endogenous amount of oxalate to that used to induce
CaOx crystallization.

Subjects and urine collection
Twenty-four hour urine specimens were obtained
from 28 healthy women (median age 26: range 17-62
years) and 37 healthy men (median age 34: range 18-62
years); the difference in age between the men and women was not significant. Urine samples were refrigerated
during the collection period and during storage prior to
use (always within 12 hours of completion of the collection) , each specimen was tested to exclude the presence
of blood using Multistix test strips (Miles Laboratories,
Mulgrave, Victoria, Australia). Data reported in this
study consisted of a combination of previous and recent
work. Therefore, although complete crystallization data
were available for all individuals, values for pH, and
calcium, urate and oxalate concentrations were not available for all subjects.

Scanning electron microscopy (SEM)
At the end of seven of the experiments (3 females,
4 males) , 2.0 ml aliquots of urine were filtered through
0.22 µm Millipore filters, and the filters were prepared
for SEM according to the method used by Grover et al.
(12]. The filtered crystals were then visualised by SEM,
using an ETEC AutoScan electron microscope (Siemens
AG, Stuttgart, Germany). To avoid bias, the operator
was blinded with regard to the sex of the individual from
whom the crystals had been obtained.

Crystalli7.ation experiments
Urines were centrifuged at 20°C for 30 minutes at
10,000 x g in a J2-21M/E centrifuge (Beckman Instruments, Palo Alto, CA), and then filtered through 0.22
µm pore-size filters (GSWP04700; Millipore Corp. ;
Bedford, MA). The minimum amount of oxalate required to induce crystallization and the urinary inhibitory
activity were then assessed by the oxalate load method
ofRyall et al. (28], using a Coulter Counter model TAIi
fitted with a 70 µm orifice and Population Count accessory (Coulter Electronics Ltd, Herts. , U.K.). The crystallization parameters measured were: (1) the metastable
limit; defined as the minimum amount of oxalate necessary to induce detectable ( > 2 µm) CaOx crystals in 20
ml of urine; (2) the total particle volume deposited at 90
minutes; and (3) the particle size, expressed as the peak
of the volume distribution curve at 90 minutes.
Six estimates of each parameter were obtained for
each urine and the mean of these values was used for
comparative purposes. In order to compare the overall

Analytical procedures
Analytical procedures were carried out on unprocessed, 24 hour whole urine samples with the exception
of the urinary pH which was measured immediately before the beginning of the experiments in centrifuged and
filtered (0.22 µm Millipore) urine, at room temperature,
and using a glass electrode. Calcium was determined by
atomic absorption spectroscopy, oxalate by the technique
of Mazzachi et al. (20], and urate by a standard autoanalyser technique.

Statistics
Values were compared using the Mann-Whitney-U
test. A p-value < 0.05 was regarded as statistically
436
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Table 1. Urinary pH and concentrations of calcium, oxalate and urate in the urine samples from the men and women,
and their daily calcium excretion. Values are expressed as the median and range. Numbers in parentheses denote the
number of values available for calculation.

pH

men

women

significance

6.24: 5.55-6.82 (n = 13)

6.21 : 5.04-7.50 (n = 23)

none

3.7: 0.6-7 .8 (n = 29)

2.8: 0.9-7.2 (n

= 25)

none

3.95: 0.6-7.8 ((n = 25)

2.82: 0.9-7.2 (n

= 24)

p < 0.0001

mmol/1

0.29: 0.09-0.61 (n = 26)

0.33 : 0.10-0.68 (n

mmol/1

2.9 : 1.4-5.5 (n = 34)

3.3: 1.8-7.4 (n
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all particle size was similar for both sexes, being 7 .1 µm
(Fig. 3). SEM confirmed this similarity in overall size
by showing that although the individual crystals precipitated from the men's urines (Fig. 4) tended to be smaller
than those from the women (Fig. 5), they were clustered
into larger aggregates than those occurring in the women' s urines . Thus, the overall sizes of the crystalline
particles precipitated from the women's and men's
urines, expressed as the positions of the peak of the particle volume distribution curves, were indistinguishable.
There were no correlations between the volume of crystalline material deposited and the urinary pH, the total
urinary concentration of oxalate, and the urinary concentrations of Ca and urate. Similarly, no correlation was
found between the metastable limit and the urinary pH,
the total urinary oxalate concentration, and the urinary
urate concentration. However, as we have shown in a
previous study already [29], an inverse correlation existed between the urinary Ca concentration and the metastable limit (women: r = -0.41, n = 25, p < 0.001 ;
men: r = -0.58, n = 29, p < 0.001; all subjects: r =
-0.54, n = 54, p < 0.001). Likewise, as we have previously shown in another study [30], the total daily Ca
output was significantly (p < 0.001) less in the women
(2.82 mMol/day) than in the men (3.959 mMol/day).
The median values and ranges of urinary pH, and
concentrations of calcium, oxalate, and urate are presented in Table 1.

12000

.;-

= 23)

20

µ.m

Figure 3. Particle volume distribution in urines of
healthy women and men . The median volumes of the
female urines are represented in the upper curve, the
median volumes of the male urines in the lower curve.
The similar peak at 7 .1 µm indicates a similar overall
particle size in both sexes.

------------------ -----------------significant. The Spearman Rank Order Correlation technique was used to test for the existence of a relationship
between crystal volume and the urinary pH, and the total
urinary concentrations of oxalate, calcium, and urate.
These parameters were also tested for a possible relationship with the metastable limit.

Discussion

Results

The well documented disparity in the incidence of
CaOx stones between men and women suggests that sex
hormones may play a determinant role in stone forniation, either by influencing the urinary conditions which
dictate the likelihood that CaOx will precipitate, or once
this has occurred, by affecting the probability that the
precipitated crystals will be retained in the urinary collecting system. This notion is supported by the results
of one study which indicated that a higher estrogenic activity during their reproductive years appears to protect

The metastable limit of the urines was significantly
higher (p = 0.009) in the women (median 0.825: range
0.15-3.15 mmol/1 oxalate), than in the men (median
0.45: range 0.15-1.65 mmol/1 in men; Fig. 1). Figure
2 shows the total particle volume 90 minutes after the
induction of crystallization: whereas women had a significantly (p = 0.006) greater total particle volume
(44,993: range 12679-100,230 r,m3 /µJ) than the men
(36,464: range 13532-71567 µm !µ1), the average over437
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Figure

4.
Scanning
electron micrograph of
typical crystals in the
urine of a male subject.
Bar= 5 µm.

women from stone formation [33]; by corollary, administration of testosterone has been reported to promote
CaOx stone formation in rats [19] . One possible mechanism by which sex hormones might influence the likelihood of stone formation could be by determining the
concentration and/or activity of urinary inhibitors. Indeed, sex-dependent differences in the inhibitory effect
of urine on CaOx crystallization in a seeded metastable
crystallization system have previously been reported by
our laboratory [30]. Moreover, it has also been demonstrated that consumption of oral contraceptives increases
the inhibitory effect of female urine on CaOx crystallization in a similar medium [35] . However, the shortcomings of such experimental systems are now well recognised, and it is generally accepted that an organic, undiluted real urine system would more accurately reflect the
complexity of physiological conditions, and thereby provide data more likely to indicate the true effects of urinary inhibitors in vivo. In this study, therefore, parameters of crystallization were assessed in undiluted urines

of healthy men and women. No attempt was made to
standardise the subjects' diets because we wished to
compare urines of women and men under their normal
living conditions. However, all urines were standardised
insofar as a standard load of oxalate was added to all
urines at their measured metastable limits.
The metastable limit, expressed as the minimum
amount of oxalate necessary to induce crystallization, is
an empirical parameter that measures the propensity of
a urine to nucleate CaOx crystals, and was found to be
inversely related to the prevailing urinary Ca concentration, as we have already shown in a previous study [29].
The metastable limits of the female urines were significantly higher than those of the men, probably reflecting
their lower urinary concentrations of Ca, and indicating
that they were less likely to undergo precipitation of
CaOx. Primafacie, this might be considered sufficient
grounds to explain the difference in stone incidence between the two sexes, since the precipitation of insoluble
crystals is the first, and absolute, requirement for stone
438
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Figure 5. Scanning electron micrograph of typical
crystals in the urine of a
female subject. Bar = 5
µm .
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female urines were larger than those from the males.
There are two obvious mechanisms by which larger
crystals could be formed . First, they could result from
a greater amount of crystal growth, which might occur
in the presence of higher concentrations of calcium and
oxalate. The urinary concentrations of calcium were
generally lower in the female urines; nonetheless, their
endogenous oxalate concentrations were slightly higher,
and their metastable limits significantly so, which means
that the total concentration of oxalate at the commencement of the 2 hour incubation period was significantly
higher in the women's urines than in the men's. It has
been recognised for more than 20 years that the prevailing concentration of oxalate is approximately 15 times
more influential than that of calcium in determining the
likelihood that precipitation of CaOx will occur in urine,
a consequence principally of the greater concentration of
calcium in urine relative to oxalate [9]. It is possible
therefore that the increased volume of CaOx crystals observed in the women's urines may have resulted from

pathogenesis. However, nucleation of crystals is, of itself, insufficient to induce CaOx stone formation, which
also requires retention of those crystals within the urinary tract. Intuitively, it is apparent that the mass and
si:ze of precipitated crystalline particles will directly affect the probability that they will be retained in the renal
collecting system, and this is borne out by the observation that individuals who have never formed a kidney
stone pass small, single CaOx crystals, while recurrent
stone formers excrete a greater mass of crystals clustered into large aggregates [22]. Thus, male and female
urines were also compared with regard to both the total
volume and the average si:ze of CaOx crystals precipitated.
Coulter Counter analysis showed that urines from

females precipitated significantly larger volumes of crystalline particles during the 90 minute incubation period
following induction of crystallization, and this finding
was complemented by the results of SEM which clearly
revealed that the individual crystals precipitated from the
439
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of chelating agents such as citrate and Mg, the probability that CaOx crystal nucleation will occur obviously depends to a great extent on the prevailing concentrations
of Ca and oxalate: measurements of their urinary concentrations have long constituted the spearhead of stone
investigation. Although we were unable to demonstrate
a statistically significant difference in urinary Ca concentrations between the male and female groups in the
current study population, the median Ca concentration
was considerably lower in the women (2. 8 mmol/1) than
in the men (3.7 mmol/1). When these results were expressed as daily Ca output, the women (median 2. 82
mMol/day) were found to excrete significantly less Ca
than the men (median 3.959 mMol/day). These findings
are in agreement with a previous report from our laboratory (30] and to other reports (4, 23, 33, 34]. We were
also unable to demonstrate a significant difference between the urinary oxalate concentrations between the two
sexes (0.29 in men and 0.33 mmol/1 in women), which
is in agreement with other reports in the literature (3, 5,
10, 15, 22, 30]. Only one study reported a lower urinary oxalate concentration in females (34].
Another urinary factor thought to influence the likelihood of CaOx stone disease is the urinary excretion of
uric acid. Several mechanisms have been advanced to
explain the apparent relationship between the two, including epitaxial deposition of CaOx upon crystals of sodium urate [6] and mitigationofurinary glycosaminoglycan inhibitory activity by colloidal particles of sodium
urate (24]. However, direct supporting evidence for
both these theories is lacking (26]. Nonetheless, other
work has shown that increasing the concentration of
urate in urine promotes CaOx crystallization (12, 13, 14,
16], and that the effect is probably wrought by the process of "salting out" (12, 13, 14, 16]. The urinary excretion of urate has been reported to be similar in the two
sexes (18], and to be increased in males (8, 30]. Contrary to our earlier observations (30], results presented
in the current study reveal an increased median urinary
uric acid concentration in females, which, though significant, was nonetheless only minor. The median urinary
concentration in women was 3.3 mmol/1 and in men 2.9
mmol/1: salting out of CaOx by urate requires increases
in urate concentration of the order of 2-3 mmol/1 (12,
13, 14], which is many times greater than the difference
in concentration between men and women found here.
Thus, it is unlikely that our finding of a higher urate excretion in women is of any significance in determining
the incidence of CaOx stone formation. This is supported by the fact that we were unable to document any correlation between urinary urate and either the deposited
crystal volume or the metastable limit.
Although urinary pH is known to affect the solubility of CaOx, we could not show any difference in pH

the higher concentrations of oxalate required to induce
crystal nucleation. However, this is unlikely because we
were unable to detect any correlation between crystal
volume and total oxalate concentration.
An alternative explanation for the larger crystal volume in the women's urines could be an enhanced inclusion of organic material into the crystalline structure,
which would increase the volume, but not the mass of
the precipitated crystals. In two other studies, in which
CaOx deposition was also measured using 14C-oxalate,
we showed that a similar increase in volume was not the
result of an enhanced deposition of solute, but was probably caused by the inclusion into the crystals of organic
matrix material (7, 32]. We therefore assume that the
increased crystal volume and larger individual crystal
size that we observed in the material precipitated from
the women's urines may have resulted from an increased
inclusion of organic matrix macromolecules into the
crystals. This is supported by the simultaneous observation that the crystals deposited from the men's urines,
although smaller than those from the women's, were
more highly aggregated: the organic matrix of urinary
CaOx crystals is known to inhibit CaOx crystal aggregation occurring in undiluted, ultrafiltered human urine
[7]. Moreover, this inhibitory effect can probably be attributed principally to the predominant protein in this
matrix, urinaryprothrombinfragment 1 (UPTFl), which
has been shown to be the most potent macromolecular
inhibitor of both CaOx crystal growth and aggregation
in this experimental crystallization system (32].
However, although the reduced degree of aggregation of the crystals precipitated from the women's urines
might suggest that they would be less likely to retain
precipitated crystals of CaOx in their kidneys, such an
advantage would be offset to some extent by their formation of larger individual crystals, which as discussed
above, occupy a greater total volume. In fact, the results presented here indicate that the potential benefit
offered by a reduced degree of crystal aggregation was
completely negated by the corresponding increase in the
size of the individual crystals and total particle volume.
Coulter Counter analysis demonstrated that the position
of the mode of the volume size distribution curve of the
crystalline particles precipitated from the women's
urines was indistinguishable from the corresponding
male value, being 7 .1 µm for both. This would suggest
that, once formed, crystalline particles precipitated from
both sexes are equally likely to be retained in the urinary
tract, and that physicochemical events subsequent to
crystal nucleation do not explain the higher incidence of
CaOx stone disease in men.
Although it is well accepted that the overall degree
of supersaturation of urine with CaOx depends upon a
number of factors, including pH and the concentrations
440

CaOx crystallization in urine of men and women
line particles more likely to be retained in the renal collecting system.

between men and women, which is in agreement with
the findings of Robertson et al. [25]. To exclude pH
changes during storage, pH was measured immediately
before the beginning of each experiment, thus, reflecting
the true experimental pH conditions. Furthermore, there
was no correlation between pH and any of the measured
crystallization parameters.
Another important urinary constituent which is
known to influence urinary saturation with CaOx is citrate, which possesses the ability both to chelate Ca ions
in solution and to inhibit CaOx crystal deposition in undiluted human urine [28], probably by binding to the
crystal surface. Unfortunately, owing to the partly retrospective nature of this study, data for urinary citrate
concentrations were not available for our patients. Urinary citrate concentration is reportedly higher in women
during their reproductive years than in men. Estrous
phase-related alterations in urinary concentration and a
marked decrease in citrate excretion in menopausal
women suggest that urinary citrate concentration is influenced by female sex-hormones, i.e., estrogen, thus, offering another possible mechanism for the relative protection of females from urinary stone formation [33, 34].
However, we believe that such an explanation is not supported by the results of the present study, since there
was no difference between men and women with respect
to the total volume of CaOx precipitated in their urines.
Moreover, although citrate has been shown to affect
CaOx crystal nucleation and aggregation [ 11, 17, 27],
those studies were performed in inorganic solutions
whose ionic conditions bear little resemblance to those
of human urine. In fact, the lack of difference between
the size of the crystalline particles precipitated in the
urines from the men and women is in accord with the
fact that urinary citrate does not affect the aggregation
of CaOx crystals in undiluted human urine using the
same experimental system as was employed here [31].
In summary, the results of this study have confirmed the findings of our previous study [30] that urine
from women inhibits CaOx crystal aggregation more
strongly than that from men. However, although this
would serve to protect females from stone disease, the
advantage is offset by the tendency of their urines to
precipitate larger individual crystals. On the other hand,
there was a clear distinction between the sexes with regard to the propensity of their urines to undergo spontaneous CaOx crystal nucleation in response to a fixed oxalate challenge, which is probably attributable to the fact
that men excrete urine containing higher concentrations
of Ca. The reason why men have a higher incidence of
CaOx stone formation remains far from clear, but it
seems to be associated with an increased tendency of
their urines to nucleate CaOx crystals per se, rather than
to factors predisposing to the formation of larger crystal-
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Discussion with Reviewers
R.P. Holmes: Would control of fluid intake prior to
and during the urine collection be useful to amplify the
inherent differences in excretions and crystallization
properties between the sexes?
Authors: Standardising fluid intake might certainly
magnify any differences between the urinary calcium
concentrations in men and women. However, the object
of this study was to compare CaOx crystallization parameters in the urine of men and women under normal,
everyday conditions. Normalising fluid intake would
simply serve to introduce an artificial, confounding
factor.

R.P. Holmes: Results from your laboratory [37] suggest that UPTF 1 will be the major protein incorporated
into the crystals formed in the experiments reported
here. Recent studies by Dussol et al. [38] of a limited
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H.-G. Tiselius: The authors have previously stated that

number of calcium oxalate stones indicate that this protein is not a major component. Does this disparity in
composition suggest that inducing crystallization with an
oxalate load creates artefactual results, or is stone matrix
predominantly inter-crystalline and differs considerably
from intra-crystalline proteins?
Authors: Dussol et al. [38] did not detect the presence
of UPTF 1 in stones for the simple reason that they did
not look for it. In fact, we have detected UPTF 1 in 9
of 10 CaOx stones, thereby confirming the validity of
the experimental model we use and providing indirect
evidence that proteins in stones are intra-crystalline [42].

centrifugation and filtration of urine remove important
macromolecules from solution [37]. Could such a mechanism have affected the result?
Authors: Removal from urine of Tamm-Horsfall mucoprotein by both low speed centrifugation and filtration is
now widely acknowledged, and this protein would have
been absent from both male and female urines alike.
Other macromolecules can be removed from urine by
filtration through certain types of membranes (Type GS
Millipore), but this does not occur with the membranes
used in this study (Type GV). The urines from the male
and female subjects were therefore equivalent in that
they were both free of Tamm-Horsfall mucoprotein, but
still contained their normal complements of other macromolecules.

B. Hess: How do the authors explain that there is no
correlation between total urinary oxalate concentrations
and crystal volumes?
Authors: If crystal mass (and volume) were determined
solely by the mineral content then we would expect a direct correlation between total crystal volume and total
oxalate concentration (and total calcium concentration).
The fact that they are not correlated suggests that other
factors contribute to crystal volume. Because proteins
are known to be included into CaOx crystals and to occupy a significant space, we have speculated that this is
the reason for the lack of correlation, as has been previously discussed [7 , 32] .

H.-G. Tiselius: The addition of oxalate increases the
supersaturation (the ion activity product) of calcium oxalate, and if the crystal nucleation was exactly the same
in urine from men and from women, the siz.e in crystal
volume should be expected to be similar. Although the
Coulter Counter technique is useful for assessing the
early steps of the crystallization, it bas definite limitations, attributable to the fact that crystals with a siz.e
below 2 µm escape detection. The concentration of oxalate is thus increased until the crystals attain a siz.e exceeding this limit. If the initially formed nuclei are
more numerous in urine A than in urine B, it is likely
that the supersaturation in sample A has to be brought to
a higher level than in B in order to produce crystals detectable in by the Coulter Counter. Such a mechanism
might subsequently affect the further siz.e and volume of
the crystals. We have thus observed a higher mean
crystal volume in urine from normal subjects than in
urine from stone formers following a similar titration experiment. Although differences in the aggregation is a
possible explanation for this observation, differences in
nucleation cannot be excluded. It would be valuable to
get some comments by the authors on the methodological problems with this technique.
Authors: If crystal nucleation were exactly the same in
two different urine specimens then we would certainly
expect similar crystal volumes and siz.e, all other things
being equal. However, differences between the urinary
content of inhibitors or promoters could affect the subsequent growth of crystals and cause large differences between crystal siz.e or volume. We do, nonetheless,
agree that formation of a larger number of initial nuclei
would require a greater deposition of calcium oxalate to
enable detection using the Coulter Counter, and this
would inevitably result in an increased total deposition
of crystal volume. However, crystal aggregation, which
we know occurs in this system, will also have a very

B. Hess: What are the small rounded crystals in the
woman's urine (Fig. 5) which cannot be observed in the
man's specimen? How do the authors explain the somewhat irregular surfaces of the calcium oxalate dibydrate
(COD) crystals in the woman's urine (Fig. 5) which cannot be found in the man' s sample (Fig. 4)?
Authors: The small rounded particles are very small
calcium oxalate monohydrate (COM) crystals. We often
observe both COD and COM crystals in the same urine
specimen, although one type usually predominates. The
presence of the COM crystals here should therefore be
regarded as a normal occurrence.
We also often observe mixed aggregates of COD
and COM. It is not uncommon to see COM crystals
bound to the surface of COD crystals, and these tend to
become enveloped by the advancing crystal growth front
and become embedded inside the structure. These are
visible as lumps on the surface of the larger crystals,
and this is the source of the surface irregularities in
Figure 5. In fact, careful scrutiny of Figure 4 shows
that in the center of the micrograph there is a COD
crystal to which bas bound a smaller COD crystal which
bas then been overgrown with CaOx. The effect is
more common when there is a mixture of small and
large particles, and is not confined specifically to either
sex.
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creased urinary metastability in women suffering less
from calcium oxalate stone disease than men in the light
of the results of Kavanagh [39]?
Authors: It is important that nucleation rate is not confused with our measurement of metastable limit. One is
the rate at which nucleation proceeds; the other is simply
an empirical measure of the amount of oxalate necessary
to begin and allow detection of the process. We have
previously shown that the amount of oxalate required to
induce observable crystal nucleation is inversely proportional to the endogenous calcium concentration: because
the women's urines had lower concentrations than the
men's, their metastable limits were higher, which is consistent with their having a decreased tendency to precipitate calcium oxalate spontaneously. We have also shown
previously that stone formers have lower metastable
limits than healthy controls, so using the same methodology, our data on women and men are in accord with
those of stone formers and normals. We can only assume therefore that the apparent disparity in the findings
relates to differences in methodology. We do not measure nucleation rates (see reply to Dr. Tiselius above) and
so cannot make any direct comparison with Dr.
Kavanagh' s results [39].

marked effect, as Prof. Tiselius acknowledges. Because
of detection limits with the Coulter Counter, 1t 1s not
possible to measure crystal nucleation. It is important to
note that this same deficiency applies to any method for
measuring particle size; estimates of nucleation rates are
always arrived at by extrapolation. We recognised this
problem ten years ago when we pointed out that the detection limit of the Coulter Counter introduced inaccuracies in the experimental estimation of inhibition, and
proposed the use of a computer model [40]. Unfortunately, this model cannot be used in the self-nucleating
crystallization system we use, and we abandoned the use
of crystal numbers as an estimate of crystal aggregation
in this technique many years ago. The technique does,
however, still provide useful estimates of the bulk of
calcium oxalate precipitated and the size of the aggregated particles.

J.M. Baumann: Differences in urine with respect to
calcium oxalate metastability may be explained by a
different activity of promoters and inhibitors. Glycosaminoglycans (GAGs) are such substances but they are
also secreted in the female genital tract. Therefore, the
question arises how 24 hour urine was collected in women, and if the difference in crystallization conditions between men and women could not be explained by a contamination of the female urine from the genital tract.
Authors: Urine was collected from the women with the
use of a plastic collecting funnel : collection of midstream urine specimens would have been impractical and
would have resulted in the loss of significant quantities
of the 24 hour volume. It is doubtful that GAGs from
the genital tract would explain the observed differences ,
in view of the fact that the most common GAG , chondroitin sulphate, has no appreciable effect on CaOx
crystallization in our experimental system [41].
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J.M. Baumann: What was the reason for the six-fold
repetition of the crystallization test in each urine. How
is the reproducibility of the test system used and what is
the coefficient of variation, respectively?
Authors: The experiments are performed in hextuplicate in order to guarantee acceptable statistical reliability. The coefficient of variation for the estimation of the
metastable limit is 5.6% and for crystal volume, is 6.7%
[28].
J.M. Baumann: Crystal nucleation in tissue seems to
be responsible for kidney calcification, which is thought
to be important for stone formation. However, in urine
of healthy controls compared to stone formers,
Kavanagh [39] found an increased nucleation rate and a
decreased metastability with respect to calcium oxalate.
How do the authors interpret their findings of an in444

